{"name":"Universidade Federal de Sergipe","slug":"universidade-federal-de-sergipe","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Piroxicam-Beta-Cyclodextrin","genericName":"Piroxicam-Beta-Cyclodextrin","slug":"piroxicam-beta-cyclodextrin","indication":"Rheumatoid arthritis","status":"phase_3"}]}],"pipeline":[{"name":"Piroxicam-Beta-Cyclodextrin","genericName":"Piroxicam-Beta-Cyclodextrin","slug":"piroxicam-beta-cyclodextrin","phase":"phase_3","mechanism":"Piroxicam-beta-cyclodextrin is a nonsteroidal anti-inflammatory drug (NSAID) formulated with beta-cyclodextrin to improve solubility and bioavailability, inhibiting cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation.","indications":["Rheumatoid arthritis","Osteoarthritis","Acute musculoskeletal pain and inflammation"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQVUxaUy1mdlVrWWxGZ1JpY2RGdVF3cVU5U29vLTEwTHNJU3VCYzJNbE0yZVVGM0ptWlpWUkI5amNjN05mckJ3QzdwczdhVnBDZEVoQjcyR2ZGV0Y5WUlENG9xeUN3R20xVElOeVFGQ29WbjVTUzN0WkJ2UTVrcksyVWIwT0NNOW9zb3c0S0tKeVkzZ0MzWElnVEVqd2JBeGhZT3duX3dDZ3RDRlZCWGc?oc=5","date":"2025-01-06","type":"pipeline","source":"Université Paris Cité","summary":"The Department of Pharmacy strengthens its ties with several Brazilian universities - Université Paris Cité","headline":"The Department of Pharmacy strengthens its ties with several Brazilian universities - Université Paris Cité","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1tV0RVb3hjTFlSWGFJR016cVV2NW90Y0xWamNIM1ZRekp5S0ZGZnpxRUhqUDBHRjFOb1FiMnA3ZjVmeEZRYVI4UlhTTzItY1BFN2VTVHRmTGxnbXc4d00zOGQ3NzF4b0YwZzdaMHNPSmFDZ05DZ2R0ZNIBfkFVX3lxTE9HWG1qNTNTN0F6c2U1dy1yUTNEYUxjSjVPS2ZEVGJNRzFTYmRhUmZmcjFTdWRlUk9rdzlZR0s4b1oxV0cyOHBjd012eWZtUWd5bERzQ2Z6MVozcTVQaGJucDlzb0VsNUY3RkhZUkJZWjN1RjRfbE0zTWdRekZmQQ?oc=5","date":"2021-11-10","type":"pipeline","source":"Revista Científica Multidisciplinar Núcleo do Conhecimento","summary":"Evaluation of the use of benzodiazepines among pharmacy course students at the Presidente Antônio Carlos-Barbacena-MG university center - Revista Científica Multidisciplinar Núcleo do Conhecimento","headline":"Evaluation of the use of benzodiazepines among pharmacy course students at the Presidente Antônio Carlos-Barbacena-MG un","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}